Cost of care distribution in atrial fibrillation patients: the COCAF study
暂无分享,去创建一个
Thomas Lavergne | Olivier Piot | J. Le Heuzey | L. Guize | T. Lavergne | O. Piot | J. Heuzey | Louis Guize | X. Copie | Mina Ait Said | Xavier Copie | Jean-Yves Le Heuzey | O. Paziaud | O. Paziaud | M. A. Said | M. Ait Said
[1] R B D'Agostino,et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. , 1998, Archives of internal medicine.
[2] R. Thomson,et al. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation , 2000, The Lancet.
[3] L. Shaw,et al. Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias. , 1997, The American journal of cardiology.
[4] Mark L. Greenberg,et al. Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation , 1999, Annals of Internal Medicine.
[5] D K Owens,et al. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. , 1995, JAMA.
[6] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[7] SamuelLévy,et al. Characterization of Different Subsets of Atrial Fibrillation in General Practice in France , 1999 .
[8] H. Liedholm,et al. Health care costs of heart failure: results from a randomised study of patient education , 2000, European journal of heart failure.
[9] S Capewell,et al. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996. , 2001, European heart journal.
[10] G. Naccarelli,et al. Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care. , 1999, The American journal of cardiology.
[11] R. Falk,et al. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. , 1998, Archives of internal medicine.
[12] L. Frost,et al. Decrease in mortality in patients with a hospital diagnosis of atrial fibrillation in Denmark during the period 1980-1993. , 1999, European heart journal.
[13] S. Ebrahim,et al. Cost-effectiveness of stroke prevention. , 2000, British medical bulletin.
[14] M. Rosenqvist,et al. Long‐Term Follow‐Up of Patients Treated By Radiofrequency Ablation of the Atrioventricular Junction , 1995, Pacing and clinical electrophysiology : PACE.
[15] G. Naccarelli,et al. Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. , 2000, The American journal of cardiology.
[16] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.
[17] P. Kowey,et al. Acute treatment of atrial fibrillation. , 1998, The American journal of cardiology.
[18] E. Aliot,et al. Second line pharmacological management of paroxysmal and persistent atrial fibrillation in france: a cost analysis. , 2000, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[19] B. Norrving,et al. Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective. , 1992, BMJ.
[20] S. Lévy,et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.